By vgreene, 18 March, 2015 Subsequent exams, OCT,<sup>32</sup> FA<sup>35</sup> [III/G/D], f/u, and tx intervals [I++/M/D] depending on clinical findings/ophthalmologist judgment
By vgreene, 18 March, 2015 Instruct pt to promptly report sx suggestive of endophthalmitis: eye pain/↑discomfort/↑redness, blurred/↓vision, ↑light sensitivity, ↑floaters [III/G/S]
By vgreene, 18 March, 2015 Treat/stabilize w/ 1st-line intravitreal pan-VEGF inhibitor mono-tx:<sup>37</sup> aflibercept 2 mg,<sup>38,39</sup> off-label bevacizumab 1.25 mg,<sup>40</sup> or ranibizumab 0.5 mg<sup>39</sup> [I++/G/S]
By vgreene, 18 March, 2015 Diagnose AMD w/ hx,<sup>30</sup> physical exam,<sup>31</sup> and imaging;<sup>32,33,34,35,36</sup> do not perform routine genetic testing for risk alleles [III/I/D]
By vgreene, 18 March, 2015 Return exam at 6-24 mo if asymptomatic or prompt exam for new sx suggestive of CNV [III/G/D]; OCT,<sup>26</sup> FA,<sup>27</sup> or fundus photos<sup>28</sup> as appropriate [III/G/S]
By vgreene, 18 March, 2015 Diagnose AMD w/ hx,<sup>24</sup> physical exam,<sup>25</sup> and imaging;<sup>26,27,28</sup> do not perform routine genetic testing for risk alleles [III/I/D]